Complete Table of Contents 2017
The table of contents for the latest issue of the journal ONCOLOGY: Perspectives on the Treatment of Hematologic and Solid Malignancies.
August 2017 Table of Contents
Volume 31 | Number 8
REVIEW ARTICLES
Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 1: Diagnosis, Prognosis, Symptom Control, and Local Treatment Vyshak Alva Venur, Pauline Funchain, Rupesh Kotecha, et al
Circulating Tumor DNA as a Liquid Biopsy: Current Clinical Applications and Future DirectionsKimberly M. Komatsubara and Adrian G. Sacher
How an Expert Approaches It
Management of Castration-Resistant, Taxane-Resistant Prostate CancerTomasz M. Beer
Comorbidity Consult
Management of Sleep-Wake Disturbances Comorbid With CancerAnn M. Berger, Ellyn E. Matthews, and Ashley M. Kenkel
Point/Counterpoint
POINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?Camille Berriochoa, Carisa Bohnak, Nicole Chahine, and Chirag Shah
COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?William C. Wood
Q&A
Fay Hlubocky on Recognizing and Addressing Clinician Burnout
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“These results and the lack of systemic toxicity observed with [TTFields] provide patients with a promising new treatment option,” according to Joachim Aerts, MD, an investigator of the phase 3 LUNAR trial (NCT02973789).](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F7d7dfad7849391f4be3ebd2cf39c24f5369cfcd1-1200x1176.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "“These results and the lack of systemic toxicity observed with [TTFields] provide patients with a promising new treatment option,” according to Joachim Aerts, MD, an investigator of the phase 3 LUNAR trial (NCT02973789).")
